Immunostimulatory combination for the prophylactics and treatment of hepatitis C

摘要

The invention relates to an immunostimulatory combination for the prophylactics and treatment of hepatitis C. The inventive combination is characterised in that it comprises: a TLR3 agonist, a CD40 agonist and protein NS3 of the hepatitis C virus. The invention also relates to pharmaceutical compositions comprising the aforementioned immunostimulatory combination, to the use of said pharmaceutical compositions and to a kit comprising same. The invention further relates to a method of producing an immune response to the hepatitis C virus and to a vaccine against said virus.